Ratings by Singular Research (Chris Sakai)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/15/2024 | QuinStreet, Inc. | QNST | Upgrade | Buy (Hold) |
16.80 (13.33) |
-20.65% | Details | |
| 3/21/2024 | Silvercrest Asset Management | SAMG | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2024 | Silvercrest Asset Management | SAMG | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2024 | Riot Platforms | RIOT | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2023 | Silvercrest Asset Management | SAMG | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2023 | QuinStreet, Inc. | QNST | Maintain | Buy-Long Term (N/A) |
|
Details | ||
| 8/23/2023 | Riot Platforms | RIOT | Upgrade | Buy (Buy-Long Term) |
10.55 (27.50) |
160.66% | Details | |
| 5/31/2023 | Riot Platforms | RIOT | Downgrade | Buy-Long Term (Buy) |
12.03 (27.50) |
128.6% | Details | |
| 3/16/2023 | Silvercrest Asset Management | SAMG | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2023 | Silvercrest Asset Management | SAMG | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2023 | XORTX Therapeutics | XRTX | New Coverage | Buy-Venture (N/A) |
0.61 (2.17) |
255.74% | Details | |
| 2/16/2023 | QuinStreet, Inc. | QNST | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2022 | BIGG Digital Assets Inc. | BBKCF | Downgrade | Buy-Long Term (Buy) |
0.18 (0.05) |
-72.22% | Details | |
| 11/16/2022 | Riot Blockchain | RIOT | Maintain | Buy (N/A) |
|
Details |
